These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22687588)

  • 1. Stress testing in patients with hypertrophic cardiomyopathy.
    Argulian E; Chaudhry FA
    Prog Cardiovasc Dis; 2012; 54(6):477-82. PubMed ID: 22687588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
    Shah JS; Esteban MT; Thaman R; Sharma R; Mist B; Pantazis A; Ward D; Kohli SK; Page SP; Demetrescu C; Sevdalis E; Keren A; Pellerin D; McKenna WJ; Elliott PM
    Heart; 2008 Oct; 94(10):1288-94. PubMed ID: 18032461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.
    Olivotto I; Montereggi A; Mazzuoli F; Cecchi F
    G Ital Cardiol; 1999 Jan; 29(1):11-9. PubMed ID: 9987042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standing position alone or in combination with exercise as a stress test to provoke left ventricular outflow tract gradient in hypertrophic cardiomyopathy and other conditions.
    Dimitrow PP; Cheng TO
    Int J Cardiol; 2010 Sep; 143(3):219-22. PubMed ID: 20442001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
    Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
    Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vagal enhancement due to subendocardial ischemia as a cause of abnormal blood pressure response in hypertrophic cardiomyopathy.
    Kawasaki T; Azuma A; Kuribayashi T; Akakabe Y; Yamano M; Miki S; Sawada T; Kamitani T; Matsubara H; Sugihara H
    Int J Cardiol; 2008 Sep; 129(1):59-64. PubMed ID: 17651826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy: genotype-positive, phenotype-"almost" negative. Diagnostic role of exercise in provocation of left ventricular outflow tract gradient.
    Dimitrow PP; Cheng TO
    Int J Cardiol; 2014 Dec; 177(3):736-7. PubMed ID: 25449499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of changes in QRS width and in ST-T segment during exercise test in hypertrophic cardiomyopathy for identification of associated coronary artery disease.
    Cantor A; Yosefy C; Potekhin M; Ilia R; Keren A
    Int J Cardiol; 2006 Sep; 112(1):99-104. PubMed ID: 16356568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy.
    Efthimiadis GK; Giannakoulas G; Parcharidou DG; Pagourelias ED; Kouidi EJ; Spanos G; Kamperidis V; Gavrielides S; Karvounis H; Styliadis I; Parcharidis GE
    Int J Cardiol; 2011 Dec; 153(2):179-84. PubMed ID: 20851477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Left intraventricular gradients measured by Doppler echocardiography at rest, during exercise and during isoproterenol test in hypertrophic cardiomyopathy].
    Decoulx E; Goullard L; Millaire A; Lecroart JL; de Groote P; Houdas Y; Ducloux G
    Arch Mal Coeur Vaiss; 1992 Jun; 85(6):839-45. PubMed ID: 1417402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
    Sorensen LL; Liang HY; Pinheiro A; Hilser A; Dimaano V; Olsen NT; Hansen TF; Sogaard P; Nowbar A; Pisanello C; Pozios I; Phillip S; Zhou X; Abraham R; Abraham TP
    Am Heart J; 2017 Feb; 184():47-54. PubMed ID: 27892886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of treadmill exercise echocardiography in the evaluation of symptomatic hypertrophic cardiomyopathy with latent obstruction. Impact on therapeutic decisions.
    Almeida AR; Cotrim C; Alves LB; Almeida S; Miranda R; Stuart B; Carrageta M
    Rev Port Cardiol; 2010 Dec; 29(12):1867-71. PubMed ID: 21428141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
    Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
    Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry.
    Ciampi Q; Olivotto I; Gardini C; Mori F; Peteiro J; Monserrat L; Fernandez X; Cortigiani L; Rigo F; Lopes LR; Cruz I; Cotrim C; Losi M; Betocchi S; Beleslin B; Tesic M; Dikic AD; Lazzeroni E; Lazzeroni D; Sicari R; Picano E
    Int J Cardiol; 2016 Sep; 219():331-8. PubMed ID: 27348413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy.
    Cambronero F; Vilchez JA; García-Honrubia A; Ruiz-Espejo F; Moreno V; Hernández-Romero D; Bonacasa B; González-Conejero R; de la Morena G; Martínez P; Climent V; Valdés M; Marín F
    Thromb Res; 2010 Jul; 126(1):e46-50. PubMed ID: 20156645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy.
    Sorajja P; Allison T; Hayes C; Nishimura RA; Lam CS; Ommen SR
    Am J Cardiol; 2012 May; 109(10):1494-8. PubMed ID: 22356797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The evolution of the arterial pressure during a stress test in patients with hypertrophic myocardiopathy].
    Bronze L; Santos L; Ventosa A; Ferreira J; Palos JL; Mendes M; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1995 Sep; 14(9):629-36. PubMed ID: 7576763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting ST-segment depression predicts exercise-induced subendocardial ischemia in patients with hypertrophic cardiomyopathy.
    Kawasaki T; Azuma A; Kuribayashi T; Taniguchi T; Miyai N; Kamitani T; Kawasaki S; Matsubara H; Sugihara H
    Int J Cardiol; 2006 Feb; 107(2):267-74. PubMed ID: 16412807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Review of Stress Testing in Hypertrophic Cardiomyopathy: Assessment of Functional Capacity, Identification of Prognostic Indicators, and Detection of Coronary Artery Disease.
    Tower-Rader A; Betancor J; Lever HM; Desai MY
    J Am Soc Echocardiogr; 2017 Sep; 30(9):829-844. PubMed ID: 28688858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.